[Primary transitional cell carcinoma of the prostate gland].
Bukharkin
B V
BV
Sorokin
K V
KV
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002295:Carcinoma, Transitional Cell / Q000145:classification / Q000473:pathology* / Q000628:therapy; D003131:Combined Modality Therapy; D006801:Humans; D008297:Male; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000145:classification / Q000473:pathology* / Q000628:therapy; D011878:Radiotherapy; D015996:Survival Rate
D000970:Antineoplastic Agents